Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
CytoMed Therapeutics Limited - Ordinary Shares
(NQ:
GDTC
)
1.600
UNCHANGED
Streaming Delayed Price
Updated: 2:09 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
434
Open
1.600
Bid (Size)
1.550 (13)
Ask (Size)
1.750 (20)
Prev. Close
1.600
Today's Range
1.600 - 1.600
52wk Range
1.420 - 5.500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 19, 2024
Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!
Via
InvestorPlace
CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers
July 17, 2024
Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybrid Gamma Delta Natural Killer T (γδ NKT) cells technology
From
CYTOMED THERAPEUTICS LIMITED
Via
GlobeNewswire
Performance
YTD
-63.72%
-63.72%
1 Month
-18.78%
-18.78%
3 Month
-20.40%
-20.40%
6 Month
-26.94%
-26.94%
1 Year
-54.15%
-54.15%
More News
Read More
Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration
March 20, 2024
Via
Spotlight Growth
CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration
March 20, 2024
Via
ACCESSWIRE
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
March 18, 2024
From
CYTOMED THERAPEUTICS LIMITED
Via
GlobeNewswire
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
March 04, 2024
From
CYTOMED THERAPEUTICS LIMITED
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 07, 2024
Via
Benzinga
US Stocks Gain; Uber Posts Upbeat Sales
February 07, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 07, 2024
Via
Benzinga
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
January 29, 2024
From
CYTOMED THERAPEUTICS LIMITED
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 27, 2023
Via
Benzinga
Singapore’s Journey to Becoming a Biotech Powerhouse
October 24, 2023
Via
Spotlight Growth
Topics
Economy
Exposures
Economy
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 09, 2023
Via
Benzinga
CytoMed Expands Research Collaboration into China After Entering Into MOU
August 29, 2023
Via
ACCESSWIRE
Singapore’s Leap into the Future of Cell and Gene Therapies
August 29, 2023
Via
Spotlight Growth
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
August 19, 2023
Via
Talk Markets
The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology
July 27, 2023
Via
Spotlight Growth
Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023
July 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 12, 2023
Via
Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.